Terns Pharmaceuticals (TERN)

• Market cap: $5.06B
• 1 day: 5.15%
• 5 days: 9.36%
• 1 month: 23.1%
• 3 months: 5.7%
• 6 months: 552.45%
• Year to date: 15.98%
• 1 year: 1,248.41%
• 5 years: 87.2%
• 10 years: 152.96%
• Sector: Healthcare
• Industry: Biotechnology

About: Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Employees: 59